2016 clinical evidence confirms that adding LumaGEM®Molecular Breast Imaging (MBI) to mammography as a secondary screening method is more than twice as effective as mammogram and ultrasound in detecting cancer for women with dense breast tissue
Recalls for Women in their 40s Also Reduced According to Abstract Presented by Solis Mammography at Radiological Society of North America's Annual Meeting in Chicago
